Business Model Breakdown
How Aeluma Inc Makes Money
ALMU
Market Cap
$290M
Annual Revenue
$6M
Profit Margin
-52.5%
The Short Version
Aeluma Inc. develops and licenses advanced silicon photonics and quantum materials, specifically quantum dot lasers and quantum nonlinear materials, for high-growth applications like optical AI and next-generation data communications. They aim to integrate their proprietary technology into partners' platforms (like Tower Semiconductor and Sumitomo Chemical) and sell their specialized components or solutions, potentially through licensing or direct sales of high-performance modules. The company's technology is designed to enable faster, more energy-efficient data processing, crucial for the future of AI and large-scale data centers.
Where the Revenue Comes From
Sales of specialized components/modules incorporating quantum technology (~100% of current revenue)
Potential licensing fees (expected future stream)
Contract revenue from government and strategic partners (e.g., ~$4M from U.S. government contracts)
Who buys: Government entities, large semiconductor manufacturers, data center operators, AI hardware developers, telecommunications companies.
Why It Works (Competitive Advantages)
- ✔Proprietary quantum dot laser and quantum nonlinear materials technology and IP.
- ✔Strategic partnerships with industry leaders (Tower Semiconductor, Sumitomo Chemical) providing manufacturing and scaling capabilities.
Economic Moat: Narrow (Intangible Assets/IP (proprietary quantum dot laser and quantum nonlinear materials technology), Switching Costs (for partners integrating their specialized platforms))
What Our Analysis Says
DVR Score as of April 20, 2026
Aeluma Inc. operates in the high-growth silicon photonics and optical AI sectors, offering substantial long-term market potential with its proprietary quantum dot laser and quantum nonlinear materials technology. The recent securing of over $4 million in non-dilutive U.S. government contracts, along with strategic partnerships with Tower Semiconductor and Sumitomo Chemical, provides crucial validation and potential scaling opportunities. The company maintains a strong balance sheet with $38.6 million in cash (as of Q2 FY26) and previously reported high liquidity. However, Q2 fiscal 2026 revenue declined YoY, full-year guidance remains weak, and the company is unprofitable with significant cash burn. Insider selling of over $5.4 million in the last quarter introduces a new cautionary note, offsetting some of the positive analyst sentiment. While the company is highly speculative with an extreme valuation relative to current revenue, the foundational technology and strategic partnerships suggest a high-risk, high-reward profile for potential 10x growth if commercialization accelerates.